Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Critical Care Medicine|December 1, 2017
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter StudyJosé Garnacho-Montero, Ana Díaz-Martín, Luisa Cantón-Bulnes, et al.
Medicine|September 3, 2014
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisalMacarena Villar, María E Cano, Eva Gato, et al.
Medicina Intensiva|April 25, 2026
Management of severe infections by multi-resistant Gram-negative bacteria in critically ill patientsJosé Garnacho-Montero, María Adriaensens-Pérez, Teresa Aldabó-Pallás, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|March 11, 2017
Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID studyAntonio Gutiérrez-Pizarraya, Luis Martín-Villén, Luis Alcalá-Hernández, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 11, 2013
Efficacy and safety of caspofungin in critically ill patients. ProCAS StudyCristóbal León-Gil, Alejandro Ubeda-Iglesias, Ana Loza-Vázquez, et al.
Intensive Care Medicine|February 9, 2020
Diagnosis of severe respiratory infections in immunocompromised patientsElie Azoulay, Lene Russell, Andry Van de Louw, et al.
Critical Care (London, England)|November 30, 2019
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trialJosé M Cisneros, Clara María Rosso-Fernández, Cristina Roca-Oporto, et al.
The Journal of Infectious Diseases|April 29, 2017
Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate IncreaseViviana Sánchez-Encinales, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, et al.
Medicina Intensiva|January 20, 2023
Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter studyFrancisco Álvarez-Lerma, Mercedes Catalán-González, Joaquín Álvarez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 9, 2011
[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]Jesús Fortún, Jordi Carratalá, Joan Gavaldá, et al.
Pageof 10